![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hy2250contents.gif)
Acta Cryst. (2009). E65, m1660 [ doi:10.1107/S1600536809047564 ]
-1,3-bis[2-(5-bromo-2-oxidobenzylideneamino)ethyl]-2-(5-bromo-2-oxidophenyl)-1,3-imidazolidine}dineodymium(III) N,N-dimethylformamide hexasolvateAbstract: In the title centrosymmetric dinuclear complex, [Nd2(C27H24Br3N4O3)2]·6C3H7NO, the NdIII ion is coordinated in a slightly distorted square-antiprismatic geometry by four N atoms and four O atoms from two centrosymmetrically-related 1,3-bis[2-(5-bromo-2-oxidobenzylamino)ethyl]-2-(5-bromo-2-oxidophenyl)-1,3-imidazolidine ligands. The Nd
Nd separation is 4.5012 (12) Å.
Online 21 November 2009
Copyright © International Union of Crystallography
IUCr Webmaster